Nearly 40,000 bottles of eye drops recalled nationwide over possible contamination
Prestige Brand Holdings is recalling 39,060 bottles of Clear Eyes Maximum Itchy Eye Relief eye drops due to potential contamination. The FDA classified this as a Class II recall, indicating temporary health risks. The affected product has lot code 2552A and expires on September 30, 2027. Prestige Brands' stock (PBH) is up 1.56%.
How this was made
The 30-second read
Why it matters
The recall highlights product quality risks as PBH expands its consumer health offerings.
Market read
Regulatory recall could affect PBH's stock and signal quality control issues for similar OTC brands.
What to watch
Potential insurance coverage and limited financial exposure from the recall.
Background
Prestige Consumer Healthcare recently acquired Breathe Right brand, expanding its OTC portfolio.
Ticker impact
Prestige Consumer Healthcare (PBH) is recalling 39,060 bottles of Clear Eyes eye drops due to sterility concerns.
Potential short-term downside as investors assess liability and brand impact.
Recalls are uncommon for consumer health products and can affect sales and brand perception.
Market effects
May raise scrutiny on consumer health product safety across the sector.
Limited to U.S. market where PBH operates.
Low, as the recall concerns a niche OTC product.
Counterpoint
Recall size is small; impact on PBH's broader portfolio may be minimal.
Key entities
- CompanyPrestige Consumer Healthcare Inc.
U.S.-listed consumer health products company (ticker PBH).
- RegulatorFDA
U.S. Food and Drug Administration overseeing the recall.
